Clark Capital Management Group, Inc.
Position in DGX — Quest Diagnostics Inc
CIK 1352187
PHILADELPHIA, PA
Position in DGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$46,138,003
+$45,411,718 QoQ
Shares Held
235,422
+3850.0% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 99.69119283669326.ToString("F0")%
Shared 0.ToString("F0")%
None 0.3088071633067428.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Clark Capital Management Group, Inc. holds $65,415,843 across 6 Diagnostics & Research names. DGX ranks #1 (70.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
This page
|
235,422 | $46,138,003 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
86,509 | $14,922,802 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
4,276 | $2,101,782 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
2,880 | $1,382,947 | |
| 5 | DHR |
Danaher Corp /De/
|
3,390 | $642,744 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
405 | $227,565 |
All Filings in DGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,138,003 | 235,422 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $726,285 | 5,960 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $836,472 | 5,951 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $626,049 | 4,425 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||